Ionis Pharmaceuticals
IONS
$42.00
Share price
-1.06%
Change (1 day)
17.58%
Change (1 year)
Categories
Operating Margin for Ionis Pharmaceuticals (IONS)
Operating Margin as of April 2024 (TTM): -43.95%
According to Ionis Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -43.95%. At the end of 2022 the company had an Operating Margin of -43.95%.
Operating Margin history for Ionis Pharmaceuticals from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -43.95% | 1086.71% |
| 2021 | -3.70% | -84.12% |
| 2020 | -23.32% | -175.47% |
| 2019 | 30.90% | -343.31% |
| 2018 | -12.70% | 176.99% |
| 2017 | -4.58% | -81% |
| 2016 | -24.12% | -22.14% |
| 2015 | -30.99% | 22% |
| 2014 | -25.40% | -43.8% |
| 2013 | -45.19% | -38.17% |
| 2012 | -73.09% | -14.59% |
| 2011 | -85.57% | 51.77% |
| 2010 | -56.38% | 115.84% |
| 2009 | -26.12% | 114.4% |
| 2008 | -12.18% | -78.22% |
| 2007 | -55.94% | -80.01% |
| 2006 | -279.85% | 123.64% |
| 2005 | -125.14% | -37.56% |
| 2004 | -200.42% | 29.82% |
| 2003 | -154.38% | 150.37% |
| 2002 | -61.66% | -28.75% |
| 2001 | -86.54% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -234,760.00% | 534,052.45% | Bahamas |
 NRC Health
NRC | 32.86% | -174.77% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.